Minerva Biotechnology and Biomolecular Research
Scope & Guideline
Exploring the Nexus of Biotechnology and Molecular Discovery
Introduction
Aims and Scopes
- Biotechnology Applications in Health Sciences:
The journal explores various applications of biotechnology, particularly in health sciences, focusing on the development of novel therapeutic strategies and diagnostic tools. - Molecular Mechanisms of Disease:
Research published in the journal investigates the molecular and genetic underpinnings of diseases, aiming to elucidate pathways and mechanisms that could be targeted for treatment. - Innovative Therapeutics and Drug Development:
A core area of focus includes the discovery and development of new drugs, including the use of natural products, nanoparticles, and biopharmaceuticals in therapeutic contexts. - Cancer Research and Therapeutics:
The journal consistently emphasizes cancer research, exploring genetic, biochemical, and immunological aspects to improve treatment outcomes and patient care. - In-silico and Computational Studies:
There is a significant focus on in-silico approaches for drug discovery and biomarker identification, reflecting the growing importance of computational methods in biological research. - Environmental and Plant Biotechnology:
Research on the environmental applications of biotechnology, including the green synthesis of nanoparticles and the use of plant-derived compounds for health benefits, is also a notable area of interest.
Trending and Emerging
- Precision Medicine and Genomics:
An increasing focus on precision medicine, especially regarding genetic testing and tailored therapies, is evident, showcasing the journal's commitment to advancing personalized healthcare. - Immunotherapy and Cancer Treatment:
Emerging themes in immunotherapy, especially in the context of cancer treatment, indicate a growing interest in harnessing the immune system for therapeutic benefits. - Sustainable and Green Biotechnology:
There is a notable trend towards sustainable practices in biotechnology, including the green synthesis of nanoparticles and the use of plant-based compounds, reflecting a broader environmental consciousness. - CRISPR and Gene Editing Technologies:
The rise of CRISPR and other gene editing technologies as a research focus indicates the journal's alignment with cutting-edge advancements in molecular biology. - Microbiome Research:
Research exploring the human microbiome and its implications for health and disease is gaining traction, suggesting an increasing interest in the interplay between microbiota and human health. - COVID-19 Related Research:
Given the global pandemic, there has been a surge in research related to COVID-19, including vaccine development and the understanding of viral mechanisms, which continues to dominate recent publications.
Declining or Waning
- Traditional Pharmacology:
There seems to be a waning interest in traditional pharmacological studies, potentially due to the shift towards more innovative and targeted therapeutic approaches. - Basic Research Without Clinical Implications:
There is a noticeable decline in studies that focus solely on basic biological research without clear implications for clinical practice, as the journal increasingly emphasizes translational research. - General Studies on Infectious Diseases:
While infectious diseases remain a relevant topic, studies that do not provide novel insights into treatment or prevention strategies may be receiving less attention. - Animal Models in Drug Testing:
Research utilizing animal models for drug testing appears to be less frequent, possibly due to ethical concerns and a growing preference for alternative methods, including in-vitro and in-silico studies.
Similar Journals
Applied Biological Research
Cultivating Knowledge in Applied Biological SciencesApplied Biological Research is a dynamic journal issued by the CENTRE ADVANCEMENT APPLIED SCIENCES, specializing in the interdisciplinary fields of biochemistry, genetics, and molecular biology. With its ISSN 0972-0979 and E-ISSN 0974-4517, this journal serves as a critical platform for the dissemination of peer-reviewed research that addresses pressing challenges and innovations within biological sciences. Although currently it does not adopt an Open Access model, it is dedicated to fostering academic discourse through rigorous publication practices. The journal's impact is underscored by its Scopus rankings, which place it in the 4th and 2nd percentiles in respective categories, emphasizing its emerging influence in the scientific community. Covering research from 2020 to 2024, Applied Biological Research is positioned as an essential read for researchers, professionals, and students seeking to stay at the forefront of biological research and application. Based in the beautiful region of Jammu & Kashmir, India, this journal is committed to advancing applied sciences through innovative research and outreach.
MOLECULAR BIOTECHNOLOGY
Fostering Innovation at the Intersection of Science and TechnologyMOLECULAR BIOTECHNOLOGY, published by SPRINGERNATURE, is a pivotal journal in the fields of applied microbiology, molecular biology, biochemistry, and biotechnology. Since its inception in 1994, the journal has aimed to disseminate high-quality research that explores the intersection of molecular biology and technology, fostering advancements in biotechnology applications. With an ISSN of 1073-6085 and an E-ISSN of 1559-0305, it has established itself as a significant contributor to the scientific community, currently holding a Q3 ranking across multiple categories including Applied Microbiology & Biotechnology and Biochemistry in the 2023 metrics. Although not an open access publication, the journal remains accessible through various institutional subscriptions, providing valuable insights and findings to researchers and professionals. Given its ongoing commitment to quality and relevance, MOLECULAR BIOTECHNOLOGY serves as an essential resource for those involved in cutting-edge research and innovation in molecular biotechnology and related disciplines.
BIOTECHNOLOGY LETTERS
Transforming Ideas into Impactful Biotechnological SolutionsBIOTECHNOLOGY LETTERS is a prestigious peer-reviewed journal that has been at the forefront of biotechnology research since its inception in 1979. Published by Springer, this esteemed journal serves as a vital platform for disseminating cutting-edge research in the fields of applied microbiology, bioengineering, and biotechnology, with a focus on innovative methodologies and technologies. With an impact factor reflecting its critical contribution to the discipline, BIOTECHNOLOGY LETTERS resides in the Q2 and Q3 tiers of various scientific categories, placing it among the notable journals in the biotechnological landscape. Although it offers traditional access options and does not feature open access, the journal embraces a global readership, encouraging submissions from researchers, professionals, and students eager to explore the dynamic advancements in biotechnology. Situated in the Netherlands, it continues to shape the future of the field through relevant, impactful research that addresses contemporary challenges and opportunities in medicine and beyond.
Biotechnology Journal
Unveiling cutting-edge developments in molecular medicine.Biotechnology Journal, published by WILEY-V C H VERLAG GMBH, stands at the forefront of biotechnological research and innovation, recognized for its significant contributions to the fields of applied microbiology, molecular medicine, and broader biotechnology. With its ISSN 1860-6768 and E-ISSN 1860-7314, this journal has achieved impressive 2023 quartile rankings, positioning itself in Q1 for both Applied Microbiology and Biotechnology and Medicine (miscellaneous), and Q2 in Molecular Medicine, showcasing its impact and relevance within the scientific community. Based in Germany, the journal aims to disseminate high-quality research that drives advancements in biotechnological applications, fostering a platform for researchers, professionals, and students to engage with cutting-edge developments. With its ongoing commitment to excellence, the Biotechnology Journal is an essential resource for those seeking to stay informed about the latest trends and innovations in biotechnology.
Acta Naturae
Driving Innovation in Life Sciences ResearchActa Naturae is a peer-reviewed scientific journal published by the Russian Federation Agency for Science & Innovation, focusing on the dynamic fields of Biochemistry, Biotechnology, Molecular Biology, and Molecular Medicine. Launched in 2013, the journal has established a solid reputation in the academic community, with its articles contributing to essential advancements and discussions within these disciplines. By 2023, it has achieved notable rankings—including Q2 status in Biotechnology and Q3 in Biochemistry, Molecular Biology, and Molecular Medicine—indicating its growing influence and relevance in the scientific literature. While currently operating under a non-open access model, Acta Naturae invites researchers, professionals, and students to engage with its comprehensive research reports and reviews that span the breadth of molecular life sciences. With the aim of facilitating scientific dialogue and innovation, this journal serves as a key resource for those seeking to stay at the forefront of molecular research.
AIMS Molecular Science
Connecting Ideas, Inspiring Innovations in Molecular ScienceAIMS Molecular Science is a premier open-access journal published by the American Institute of Mathematical Sciences (AIMS), dedicated to the advancement and dissemination of high-quality research in the field of molecular science. Since its inception in 2014, this journal has established itself as a vital platform for researchers and professionals aiming to share their findings in molecular biology, chemistry, and interdisciplinary studies related to these domains. With an increasing focus on the accessibility of scientific knowledge, AIMS Molecular Science supports the open-access movement, ensuring that all published articles are freely available to the global research community. The journal emphasizes originality and significance in research, promoting innovative scientific methodologies and applications. By fostering collaboration and dialogue among scientists, AIMS Molecular Science plays a crucial role in advancing understanding and stimulating progress in molecular sciences.
ELECTRONIC JOURNAL OF BIOTECHNOLOGY
Advancing the Frontiers of Biotechnology and MicrobiologyThe Electronic Journal of Biotechnology is a premier Open Access journal published by Pontificia Universidad Catolica de Valparaiso, Chile, dedicated to advancing the fields of applied microbiology and biotechnology. With its inception in 1998 and an unwavering commitment to sharing knowledge, the journal has garnered a respectable ranking within the Q3 quartile for both its biotechnology and applied microbiology categories as of 2023, reflecting its significance in the academic community. Researchers and professionals will find its editorial rigor complemented by a robust platform for disseminating innovative findings, fostering collaboration, and driving forward biotechnology discussions. Given its inclusive approach, having transitioned to Open Access in 2014, the journal ensures that research is accessible to a global audience, making it a valuable resource for students, academics, and industry practitioners alike. Through the publication of original research, reviews, and critical insights, the Electronic Journal of Biotechnology aims to bridge the gap between scientific discovery and practical application, ultimately contributing to advancements in health, agriculture, and environmental sustainability.
CURRENT ISSUES IN MOLECULAR BIOLOGY
Pioneering Insights into Molecular Genetics and MicrobiologyCURRENT ISSUES IN MOLECULAR BIOLOGY, published by MDPI, serves as an essential forum for researchers and professionals in the rapidly evolving field of molecular biology. Established in 1999 and operating under an Open Access model, this journal not only shares high-quality research but also encourages a vibrant exchange of ideas across various disciplines, including medicine and microbiology. With an impressive trajectory leading into 2024, it has earned its place in the Q2 quartile for both Medicine (miscellaneous) and Microbiology, emphasizing its relevance and impact in these areas. The journal’s commitment to disseminating cutting-edge findings is reflected in its diverse coverage of topics, from molecular genetics to microbial interactions. Operating from its home base in Basel, Switzerland, CURRENT ISSUES IN MOLECULAR BIOLOGY is positioned to contribute significantly to the academic landscape, making it indispensable for those seeking to advance their understanding and research within the life sciences.
ACTA BIOCHIMICA POLONICA
Exploring the Frontiers of Biochemical KnowledgeACTA BIOCHIMICA POLONICA (ISSN: 0001-527X, E-ISSN: 1734-154X) is a distinguished journal published by the ACTA BIOCHIMICA POLONICA in Poland, with a rich history dating back to 1955. As a prominent platform for disseminating research, it currently holds a Category Quartile of Q3 in the fields of Biochemistry, Genetics, and Molecular Biology, reflecting its commitment to advancing knowledge in these critical areas. This journal is indexed in Scopus, ranking 124 out of 221, placing it in the 44th percentile among general biochemistry, genetics, and molecular biology journals. Although it does not operate under an open-access model, ACTA BIOCHIMICA POLONICA remains a vital resource for researchers, professionals, and students seeking to delve into the latest developments and discoveries in biochemistry and molecular biology. Its strategic focus on contemporary topics ensures that it plays an essential role in shaping future scientific inquiries and fostering collaboration across various disciplines.
Gene Reports
Exploring the Frontiers of Genetic ScienceGene Reports is a prominent academic journal published by Elsevier that focuses on the rapidly evolving field of genetics. Launched in 2015, this journal serves as a pivotal platform for the dissemination of cutting-edge research, bridging the gap between basic and applied genetics studies. Although it currently holds a Q4 ranking in the Genetics category and stands at the 248th position out of 347 in Scopus rankings, its potential for growth is significant given the increasing interest in genetic research across various disciplines. With an E-ISSN of 2452-0144, Gene Reports aims to provide open access to original research articles, reviews, and short communications that advance the collective understanding of genetic mechanisms and their applications. As a publication that continues to shape the future of genetics, it is an essential resource for researchers, professionals, and students seeking to stay informed about the latest developments in this crucial field.